Search Result

Your search results.

back 1 2 3 4 5 6 7 8 9 10 next

Home

Latest Press Releases 31.08.2010 Combination therapy of telmisartan and amlodipine provides significantly better blood pressure lowering than either agent alone For non-US and non-UK Healthcare Media only 30.08.2010 A new era for patients with atrial fibrillation - Dabigatran etexilate at the
- Size: 8 kB
- Last Update: 8.09.2010
30 August 2010 dabigatran

At the same time, Boehringer Ingelheim confirms that the U.S. Food and Drug Administration (FDA) granted a priority review designation for Boehringer Ingelheim’s novel oral direct thrombin inhibitor dabigatran etexilate for the prevention of stroke in AF.
- Size: 24 kB
- Last Update: 8.09.2010
31 August 2010

Stockholm/Sweden, 31 August 2010 - Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe hypertension.
- Size: 16 kB
- Last Update: 8.09.2010
english_final_white1.swf
- Size: 75 kB
- Last Update: 8.09.2010
e-banner-4.swf
- Size: 38 kB
- Last Update: 2.09.2010
english_final_white.jpg
- Size: 47 kB
- Last Update: 7.09.2010
english_final_white.jpg
- Size: 47 kB
- Last Update: 7.09.2010
backgrounder_Pradaxa_FINAL_changes_marked_up.pdf

 Dabigatran etexilate, a novel oral reversible direct thrombin inhibitor, is at the forefront of a new generation of oral anticoagulants targeting a high unmet medical need in the prevention and treatment of acute and chronic thromboembolic diseases
- Size: 110 kB
- Last Update: 22.08.2010
illu_dr_s-schulman.jpg
- Size: 7 kB
- Last Update: 22.08.2010
backgrounder_VTE_disease_FINAL_changes_marked_up.pdf

• Deep vein thrombosis (DVT) – a blood clot which forms in a deep vein, most commonly the calf/leg, that partially or completely blocks the flow of blood
- Size: 95 kB
- Last Update: 22.08.2010

back 1 2 3 4 5 6 7 8 9 10 next

back to top